3.8 Article

Parathyroid Hormone Signaling in Osteocytes

Journal

JBMR PLUS
Volume 2, Issue 1, Pages 22-30

Publisher

WILEY
DOI: 10.1002/jbm4.10021

Keywords

OSTEOCYTE; PARATHYROID HORMONE; SCLEROSTIN; RANKL; BONE REMODELING

Funding

  1. NIH [K08AR067295, P30AR066261, R03AR 072150]
  2. MGH Department of Medicine
  3. ASBMR (Rising Star Award)

Ask authors/readers for more resources

Osteocytes are the most abundant cell type in bone and play a central role in orchestrating skeletal remodeling, in part by producing paracrine-acting factors that in turn influence osteoblast and osteoclast activity. Recent evidence has indicated that osteocytes are crucial cellular targets of parathyroid hormone (PTH). Here, we will review the cellular and molecular mechanisms through which PTH influences osteocyte function. Two well-studied PTH target genes in osteocytes are SOST and receptor activator of NF-kB ligand (RANKL). The molecular mechanisms through which PTH regulates expression of these two crucial target genes will be discussed. Beyond SOST and RANKL, PTH/PTH-related peptide (PTHrP) signaling in osteocytes may directly influence the way osteocytes remodel their perilacunar environment to influence bone homeostasis in a cell-autonomous manner. Here, I will highlight novel, additional mechanisms used by PTH and PTHrP to modulate bone homeostasis through effects in osteocytes. (C) 2017 The Authors. JBMR Plus is published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available